IDXX
IDEXX Laboratories Inc
NASDAQ: IDXX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$560.80
+1.29% today
Updated 2026-04-30
Market cap
$44.08B
P/E ratio
42.36
P/S ratio
10.24x
EPS (TTM)
$13.07
Dividend yield
—
52W range
$465 – $770
Volume
0.5M
IDEXX Laboratories Inc (IDXX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+6.7%
Last 4 quarters
Revenue YoY growth
+14.3%
Most recent quarter
EPS YoY growth
+17.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+9.6%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+19.9%
2025-08-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-02 | $3.08 | +4.8% | $670.46 | $632.56 | -5.7% |
| 2025-11-03 | $3.40 | +7.9% | $629.51 | $722.12 | +14.7% |
| 2025-08-04 | $3.63 | +10.0% | $535.54 | $641.94 | +19.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $2.94 | $3.08 | +4.8% | $1.09B | +14.3% |
| 2025-09-30 | $3.15 | $3.40 | +7.9% | $1.11B | +13.3% |
| 2025-06-30 | $3.30 | $3.63 | +10.0% | $1.11B | +10.6% |
| 2025-03-31 | $2.84 | $2.96 | +4.2% | $998.43M | +3.6% |
| 2024-12-31 | $2.40 | $2.62 | +9.2% | $954.29M | +5.8% |
| 2024-09-30 | $2.69 | $2.80 | +4.1% | $975.54M | +6.6% |
| 2024-06-30 | $2.87 | $3.02 | +5.2% | $1.00B | +6.4% |
| 2024-03-31 | $2.67 | $2.81 | +5.2% | $964.10M | — |
| 2023-12-31 | $2.12 | $2.32 | +9.4% | $901.60M | — |
| 2023-09-30 | $2.37 | $2.53 | +6.8% | $915.53M | — |
| 2023-06-30 | $2.47 | $2.67 | +8.1% | $943.63M | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $14.82 | $4.7B | +8.9% | 9 | high |
| 2027 (E) | $16.71 | $5.1B | +8.6% | 9 | high |
| 2028 (E) | $18.22 | $5.5B | +8.4% | 9 | medium |
| 2029 (E) | $19.94 | $6.0B | +8.5% | 9 | medium |
| 2030 (E) | $21.84 | $6.5B | +8.6% | 9 | medium |
Frequently asked questions
Has IDEXX Laboratories Inc beaten earnings estimates?
IDEXX Laboratories Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +6.7% over the last 4 quarters.
How does IDXX stock react to earnings?
IDXX stock has moved an average of +9.6% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is IDEXX Laboratories Inc's revenue growth rate?
IDEXX Laboratories Inc reported year-over-year revenue growth of +14.3% in its most recent quarter, with EPS growing +17.6% year-over-year.
What is the expected EPS for IDXX in 2026?
Analysts expect IDEXX Laboratories Inc to report EPS of $14.82 for fiscal year 2026, on revenue of $4.7B, based on estimates from 9 analysts.